Statement of Changes in Beneficial Ownership (4)
April 24 2017 - 2:09PM
Edgar (US Regulatory)
FORM 4
[ ]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
|
OMB APPROVAL
OMB Number:
3235-0287
Estimated average burden
hours per response...
0.5
|
|
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
|
|
1. Name and Address of Reporting Person
*
Mann Michael Scott
|
2. Issuer Name
and
Ticker or Trading Symbol
ENDONOVO THERAPEUTICS, INC.
[
ENDV
]
|
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
_____ Director
__
X
__ 10% Owner
__
X
__ Officer (give title below)
_____ Other (specify below)
President
|
(Last)
(First)
(Middle)
6320 CANOGA AVENUE
|
3. Date of Earliest Transaction
(MM/DD/YYYY)
4/19/2017
|
(Street)
WOODLAND HILLS, CA 91367
(City)
(State)
(Zip)
|
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_
X
_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
|
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
|
1.Title of Security
(Instr. 3)
|
2. Trans. Date
|
2A. Deemed Execution Date, if any
|
3. Trans. Code
(Instr. 8)
|
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
|
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)
|
7. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
Amount
|
(A) or (D)
|
Price
|
Common Stock
|
4/19/2017
|
|
P
|
|
1000
|
A
|
$0.074
|
20238949
|
D
|
|
Common Stock
|
4/19/2017
|
|
P
|
|
1000
|
A
|
$0.0738
|
20239949
|
D
|
|
Common Stock
|
4/19/2017
|
|
P
|
|
1000
|
A
|
$0.0724
|
20240949
|
D
|
|
Common Stock
|
4/19/2017
|
|
P
|
|
1000
|
A
|
$0.0722
|
20241949
|
D
|
|
Common Stock
|
4/19/2017
|
|
P
|
|
1000
|
A
|
$0.0724
|
20242949
|
D
|
|
Common Stock
|
4/19/2017
|
|
P
|
|
1000
|
A
|
$0.0697
|
20243949
|
D
|
|
Common Stock
|
4/19/2017
|
|
P
|
|
1000
|
A
|
$0.0697
|
20244949
|
D
|
|
Common Stock
|
4/19/2017
|
|
P
|
|
1000
|
A
|
$0.0697
|
20245949
|
D
|
|
Common Stock
|
4/19/2017
|
|
P
|
|
1000
|
A
|
$0.0735
|
20246949
|
D
|
|
Common Stock
|
4/19/2017
|
|
P
|
|
1000
|
A
|
$0.077
|
20247949
|
D
|
|
Common Stock
|
4/19/2017
|
|
P
|
|
1000
|
A
|
$0.075
|
20248949
|
D
|
|
Common Stock
|
4/19/2017
|
|
P
|
|
1000
|
A
|
$0.0695
|
20249949
|
D
|
|
Common Stock
|
4/19/2017
|
|
P
|
|
1000
|
A
|
$0.07
|
20250949
|
D
|
|
Common Stock
|
4/19/2017
|
|
P
|
|
1000
|
A
|
$0.07
|
20251949
|
D
|
|
Common Stock
|
4/19/2017
|
|
P
|
|
1000
|
A
|
$0.07
|
20252949
|
D
|
|
Common Stock
|
4/19/2017
|
|
P
|
|
1000
|
A
|
$0.07
|
20253949
|
D
|
|
Common Stock
|
4/19/2017
|
|
P
|
|
1000
|
A
|
$0.07
|
20254949
|
D
|
|
Common Stock
|
4/19/2017
|
|
P
|
|
1000
|
A
|
$0.0689
|
20255949
|
D
|
|
Common Stock
|
4/19/2017
|
|
P
|
|
1000
|
A
|
$0.0678
|
20256949
|
D
|
|
Common Stock
|
4/19/2017
|
|
P
|
|
1000
|
A
|
$0.0679
|
20257949
|
D
|
|
Common Stock
|
4/20/2017
|
|
P
|
|
1000
|
A
|
$0.06
|
20258949
|
D
|
|
Common Stock
|
4/20/2017
|
|
P
|
|
2000
|
A
|
$0.0579
|
20260949
|
D
|
|
Common Stock
|
4/20/2017
|
|
P
|
|
2000
|
A
|
$0.0579
|
20262949
|
D
|
|
Common Stock
|
4/20/2017
|
|
P
|
|
1000
|
A
|
$0.0579
|
20263949
|
D
|
|
Common Stock
|
4/20/2017
|
|
P
|
|
1000
|
A
|
$0.0579
|
20264949
|
D
|
|
Common Stock
|
4/20/2017
|
|
P
|
|
1000
|
A
|
$0.0579
|
20265949
|
D
|
|
Common Stock
|
4/21/2017
|
|
P
|
|
1000
|
A
|
$0.057
|
20266949
|
D
|
|
Common Stock
|
4/21/2017
|
|
P
|
|
1000
|
A
|
$0.057
|
20267949
|
D
|
|
Common Stock
|
4/21/2017
|
|
P
|
|
1000
|
A
|
$0.0568
|
20268949
|
D
|
|
Common Stock
|
4/21/2017
|
|
P
|
|
1000
|
A
|
$0.056
|
20269949
|
D
|
|
Table II - Derivative Securities Beneficially Owned (
e.g.
, puts, calls, warrants, options, convertible securities)
|
1. Title of Derivate Security
(Instr. 3)
|
2. Conversion or Exercise Price of Derivative Security
|
3. Trans. Date
|
3A. Deemed Execution Date, if any
|
4. Trans. Code
(Instr. 8)
|
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
|
6. Date Exercisable and Expiration Date
|
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4)
|
8. Price of Derivative Security
(Instr. 5)
|
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)
|
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)
|
11. Nature of Indirect Beneficial Ownership (Instr. 4)
|
Code
|
V
|
(A)
|
(D)
|
Date Exercisable
|
Expiration Date
|
Title
|
Amount or Number of Shares
|
Explanation of Responses:
|
Reporting Owners
|
Reporting Owner Name / Address
|
Relationships
|
Director
|
10% Owner
|
Officer
|
Other
|
Mann Michael Scott
6320 CANOGA AVENUE
WOODLAND HILLS, CA 91367
|
|
X
|
President
|
|
Signatures
|
Michael Mann
|
|
4/24/2017
|
**
Signature of Reporting Person
|
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
|
*
|
If the form is filed by more than one reporting person,
see
Instruction 4(b)(v).
|
**
|
Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
See
18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
|
Note:
|
File three copies of this Form, one of which must be manually signed. If space is insufficient,
see
Instruction 6 for procedure.
|
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
|